Italia markets open in 2 hours 52 minutes

PCAS SA (0NF7.L)

LSE - LSE Prezzo differito. Valuta in EUR.
Aggiungi a watchlist
12,88-5,43 (-29,64%)
Alla chiusura: 01:29PM BST
Schermo intero
Chiusura precedente18,30
Aperto12,88
Denaro0,00 x N/D
Lettera0,00 x N/D
Min-Max giorno12,88 - 12,88
Intervallo di 52 settimane12,88 - 12,88
Volume75.000
Media VolumeN/D
CapitalizzazioneN/D
Beta (5 anni mensile)0,54
Rapporto PE (ttm)N/D
EPS (ttm)-2,95
Prossima data utiliN/D
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    1st HALF 2022 EARNINGS REPORT

    Ecully, September 8, 2022 1st HALF 2022 EARNINGS REPORT PCAS (Euronext Paris: PCA), a specialist in the development and production of complex molecules for life sciences and innovative technologies, announces the publication of its consolidated earnings for the first half of 2022. 30 June 2021 30 June 2022 in millions of euros Net sales 106.3 109.8 EBITDA (*) 8.0 -0.5 EBITDA margin 7.5% -0.5% Current operating income (*) -2.6 -15.3 Other operating income and expenses -0.4 -14.7 Operating income

  • GlobeNewswire

    PCAS: NET SALES AS OF JUNE 30, 2022

    Ecully, July 29, 2022 NET SALES AS OF JUNE 30, 2022 PCAS (Euronext Paris: PCA), a specialist in developing and producing complex molecules for life sciences and innovative technologies, has announced the publication of its consolidated net sales as of June 30, 2022. The PCAS Group has generated consolidated net sales of €109.8 million as of June 30, 2022, a 3.3% increase compared to the same period during the previous financial year (+1.4% at constant exchange rates). In millions of euros 2022 2

  • GlobeNewswire

    PCAS: NET SALES AS OF MARCH 31, 2022

    Ecully, May 13, 2022 NET SALES AS OF MARCH 31, 2022 PCAS (Euronext Paris: PCA), a specialist in developing and producing complex molecules for life sciences and innovative technologies, has announced the publication of its consolidated net sales as of March 31, 2022. The PCAS Group has generated consolidated net sales of €51.2 million as of March 31, 2022, a 1.2% decrease compared to the same period during the previous financial year (-3.0% at constant exchange rates). In millions of euros 2022